glp-1 and diabetes GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1: Actions on Beta-cell Mass

Impaired Glucose Tolerance (Off-Label): In some clinical settings, it is used to delay the progression from pre-diabetes to overt Type 2 Diabetes by reducing the metabolic stress on pancreatic beta-cells

With India and China representing ~25% of the worlds adult obese population, this shift promises a major transformation in treatment affordability and availability in high-burden regions

The macronutrient distribution varies depending on the type of KD and the purpose of the diet

Its ability to support cellular energy production and help fatigue makes it a valuable addition to any wellness regimen, particularly for those seeking to promote their neurological health and vitality

Diabetes Care 47 , 890897 (2024)